Uptake of Prevention of Mother to Child HIV Transmission (PMTCT) Option B+ ART Program among Pregnant and Lactating Mothers Attending Ante Natal Care (ANC) Clinic at Jimma University Specialized Hospital, Southwest Ethiopia

Abstract

If the mother is breastfeeding, she should also continue to take the triple-drug anti-retroviral regimen until 1 week after breastfeeding has finished. Eligibility is determined at a country level. WHO recommends women with a CD4 count of ≤ 500 cells/ mm3 (or clinic stage 3 or 4) should continue taking anti-retroviral treatment for life. This course of medication should be permanent and taken every day in order to postpone the development of HIV into AIDS. HIV-exposed infants all infants born to HIV positive mothers should receive a course of medication for PMTCT, which is linked to the drug regimen that the mother is taking and the infants feeding method. If Breastfeeding, The infant should receive Abstract